• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    3/17/23 12:49:21 PM ET
    $ACER
    $ACON
    $ANTE
    $APCX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Specialities
    Health Care
    Get the next $ACER alert in real time by email

    Gainers

    • Enzo Biochem, Inc. (NYSE:ENZ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp.
    • Histogen Inc. (NASDAQ:HSTO) climbed 60% to $1.39 after the company announced issuance of a US patent covering CTS-2090 methods of use.
    • QualTek Services Inc. (NASDAQ:QTEK) gained 56.4% to $0.4379. QualTek secured new money financing.
    • AirNet Technology Inc. (NASDAQ:ANTE) climbed 38.3% to $1.12.
    • Maxpro Capital Acquisition Corp. (NASDAQ:JMAC) gained 38% to $13.66.
    • Lixiang Education Holding Co., Ltd. (NASDAQ:LXEH) jumped 28% to $1.25.
    • Traeger, Inc. (NYSE:COOK) gained 24% to $3.7415 after the company announced better-than-expected Q4 results.
    • AppTech Payments Corp. (NASDAQ:APCX) jumped 22.8% to $1.5350.
    • Aclarion, Inc. (NASDAQ:ACON) gained 20% to $0.83.
    • Berkshire Grey, Inc. (NASDAQ:BGRY) climbed 18.3% to $1.16.
    • Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) jumped 18% to $15.98
    • Paranovus Entertainment Technology Ltd. (NASDAQ:PAVS) gained 18% to $4.63.
    • Boqii Holding Limited (NYSE:BQ) gained 15.7% to $1.10.
    • Orla Mining Ltd. (NYSE:ORLA) climbed 13.7% to $4.55 after the company reported Q4 EPS results were higher year over year.
    • Riot Platforms, Inc. (NASDAQ:RIOT) gained 10.3% to $7.78.
    • Coinbase Global, Inc. (NASDAQ:COIN) surged 9.4% to $74.15.
    • XPeng Inc. (NYSE:XPEV) gained 8.2% to $9.02 after the company reported a fourth-quarter FY22 sales decline of 39.9% year-on-year, to RMB5.14 billion ($745.28 million), missing the consensus of $834.05 million.
    • FedEx Corporation (NYSE:FDX) rose 8% to $220.32 after the company reported better-than-expected Q3 EPS and raised its FY23 outlook.
    • Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) jumped 7.4% to $13.57.
    • Baidu, Inc. (NASDAQ:BIDU) gained 6.2% to $146.74 after the company announced it has been granted the first-ever permits to provide fully driverless ride-hailing service in the Chinese capital Beijing.

    Losers

    • Lifecore Biomedical, Inc. (NASDAQ:LFCR) shares declined 61.6% to $1.9616 after the company reported worse-than-expected Q2 financial results.
    • Diebold Nixdorf, Incorporated (NYSE:DBD) dropped 53.5% to $1.07. Wedbush reiterated Diebold Nixdorf with an Outperform and maintained a $5 price target.
    • Acer Therapeutics Inc. (NASDAQ:ACER) fell 46.4% to $0.8313 after the company announced its Phase 2a trial data showing ACER-801 was safe and well-tolerated but did not achieve statistical significance when evaluating the ability to decrease the frequency or severity of hot flashes in postmenopausal women.
    • Pear Therapeutics, Inc. (NASDAQ:PEAR) declined 44% to $0.33. Pear Therapeutics announced process exploring strategic alternatives.
    • Blend Labs, Inc. (NYSE:BLND) dropped 36.5% to $0.9338 after the company reported worse-than-expected Q4 adjusted EPS and sales results.
    • Nexters Inc. (NASDAQ:GDEV) shares fell 35.7% to $3.60 after the company issued Q4 update.
    • Loyalty Ventures Inc. (NASDAQ:LYLT) dropped 26.8% to $0.1061.
    • First Republic Bank (NYSE:FRC) dropped 26.2% to $25.23 after the bank announced a deal for $30 billion in deposits from major banks and said it has decided to suspend its dividend.
    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) dropped 23.5% to $0.5050 after the company reported worse-than-expected Q4 EPS results.
    • Purple Innovation, Inc. (NASDAQ:PRPL) fell 21.6% to $2.5815 after the company reported worse-than-expected Q4 adjusted EPS results and issued Q1 revenue guidance below analyst estimates.
    • Sarepta Therapeutics, Inc. (NASDAQ:SRPT) dropped 19.9% to $119.83 after the company said that that FDA has decided to hold a public advisory committee meeting on its SRP 9001 BLA.
    • Casa Systems, Inc. (NASDAQ:CASA) fell 19.8% to $1.3950.
    • Reliance Global Group, Inc. (NASDAQ:RELI) fell 19.3% to $3.1299.
    • Montauk Renewables, Inc. (NASDAQ:MNTK) declined 19% to $7.70 after the company reported full year 2022 results.
    • RedHill Biopharma Ltd. (NASDAQ:RDHL) fell 19% to $0.1457. RedHill Biopharma announced plan to implement ADS ratio change from a 1 ADS-for-10 ordinary shares ratio to a 1 ADS-for-400 ordinary share ratio (1-for-40) on or about March 23, 2023.
    • Groupon, Inc. (NASDAQ:GRPN) fell 19% to $3.97 after the company reported worse-than-expected Q4 sales results.
    • Western Alliance Bancorporation (NYSE:WAL) dropped 17.6% to $30.34. Shares of several companies in the broader financial space traded lower on continued downward momentum in the sector amid volatility and stability concerns following multiple bank failures.
    • Impac Mortgage Holdings, Inc. (NYSE:IMH) fell 17.5% to $0.24 after posting a wider quarterly loss.
    • Pharming Group N.V. (NASDAQ:PHAR) fell 17% to $9.94 following Q4 results.
    • Semantix, Inc. (NASDAQ:STIX) dropped 16.8% to $ 3.7250.
    • CareMax, Inc. (NASDAQ:CMAX) fell 16.6% to $3.0350. CareMax said it sees FY22 revenue of $631.1 million.
    • Karooooo Ltd. (NASDAQ:KARO) dipped 15.8% to $22.00.
    • OncoCyte Corporation (NASDAQ:OCX) fell 15% to $0.2574.
    • Aspen Aerogels, Inc. (NYSE:ASPN) dropped 14.7% to $6.67.
    • Dermata Therapeutics, Inc. (NASDAQ:DRMA) fell 14% to $1.90.
    • PacWest Bancorp (NASDAQ:PACW) fell 13.3% to $ 9.93.
    • Sunnova Energy International Inc. (NYSE:NOVA) fell 14.4% to $12.59.
    • Emergent BioSolutions Inc. (NYSE:EBS) dropped 12.8% to $8.41 after JP Morgan downgraded the stock from Neutral to Underweight and lowered its price target from $23 to $9.
    • Cutera, Inc. (NASDAQ:CUTR) fell 11.1% to $24.75.
    • Sunrun Inc. (NASDAQ:RUN) dropped 10% to $17.10.
    • Metropolitan Bank Holding Corp. (NYSE:MCB) fell 10% to $35.81.
    • SL Green Realty Corp. (NYSE:SLG) dropped 9.6% to $23.77.
    • Despegar.com, Corp. (NYSE:DESP) fell 9.2% to $5.01. Despegar.com recently posted downbeat quarterly results.
    • Design Therapeutics, Inc. (NASDAQ:DSGN) dropped 8.8% to $6.41.

    Now Read This: Top 5 Tech Stocks Which You'll Regret Missing This Quarter

    Get the next $ACER alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACER
    $ACON
    $ANTE
    $APCX

    CompanyDatePrice TargetRatingAnalyst
    Western Alliance Bancorporation
    $WAL
    3/9/2026$83.00Buy → Hold
    TD Cowen
    Western Alliance Bancorporation
    $WAL
    3/9/2026$79.00Underweight → Equal Weight
    Wells Fargo
    Traeger Inc.
    $COOK
    3/6/2026$1.50 → $1.00Market Perform
    Telsey Advisory Group
    FedEx Corporation
    $FDX
    2/25/2026$335.00Hold → Reduce
    HSBC Securities
    Karooooo Ltd.
    $KARO
    2/17/2026$62.00Buy
    Roth Capital
    FedEx Corporation
    $FDX
    2/13/2026$313.00 → $383.00Buy
    TD Cowen
    Coinbase Global Inc.
    $COIN
    2/12/2026$120.00Buy → Neutral
    Monness Crespi & Hardt
    FedEx Corporation
    $FDX
    2/3/2026$380.00Equal Weight → Overweight
    Wells Fargo
    More analyst ratings

    $ACER
    $ACON
    $ANTE
    $APCX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Western Alliance Bank Names Kristen Hillenbrand Head of Treasury Management Sales

    Veteran treasury executive to lead national sales team, advance client-focused strategy Western Alliance Bank (NYSE:WAL) today announced that it has appointed Kristen Hillenbrand as Head of Treasury Management Sales, overseeing the bank's national treasury operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310685545/en/Kristen Hillenbrand, Head of Treasury Management Sales, Western Alliance Bank In this role, Hillenbrand leads a nationwide team of Treasury Management directors, officers, advisors, and payables and receivables consultants dedicated to designing and delivering tailored solutions and an elevated client

    3/10/26 6:47:00 PM ET
    $WAL
    Major Banks
    Finance

    Groupon Launches Board-Level Artificial Intelligence Committee and Appoints Amit Shah to Board of Directors

    Technology executive and AI entrepreneur to chair new committee as Company positions marketplace for the era of agentic commerceChicago, Illinois--(Newsfile Corp. - March 10, 2026) - Groupon, Inc. (NASDAQ:GRPN) today announced the appointment of Amit Shah to its Board of Directors, effective March 10, 2026, and the formation of a dedicated Artificial Intelligence Committee of the Board. Shah, a seasoned technology executive and AI entrepreneur, will serve as the Committee's inaugural Chair.With this action, Groupon becomes one of the first publicly traded consumer marketplaces to establish a board-level committee dedicated to artificial intelligence. The formation of the Committee reflects t

    3/10/26 4:15:00 PM ET
    $APRN
    $FLWS
    $GRPN
    Catalog/Specialty Distribution
    Consumer Discretionary
    Other Specialty Stores
    Advertising

    Groupon Reports Fourth Quarter and Fiscal Year 2025 Results

    North America Q4 Local Revenue +4% and Local Billings +9%North America 2025 Local Revenue +5% and Local Billings +14%Positive Trailing twelve month operating cash flow from continuing operations of $64.5 million and Free Cash Flow of $49.9 millionChicago, Illinois--(Newsfile Corp. - March 10, 2026) - Groupon, Inc. (NASDAQ:GRPN) today announced its financial results for the quarter and year ended December 31, 2025 and provided details on its recent operating progress. The Company filed its Form 10-K with the Securities and Exchange Commission and posted earnings commentary including an updated presentation on its investor relations website (investor.groupon.com)."Our 2025 results represent a

    3/10/26 4:15:00 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    $ACER
    $ACON
    $ANTE
    $APCX
    SEC Filings

    View All

    Groupon Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Groupon, Inc. (0001490281) (Filer)

    3/10/26 4:15:19 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    SEC Form 10-K filed by Groupon Inc.

    10-K - Groupon, Inc. (0001490281) (Filer)

    3/10/26 4:14:34 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Blend Labs Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Blend Labs, Inc. (0001855747) (Filer)

    3/10/26 4:01:12 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    $ACER
    $ACON
    $ANTE
    $APCX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Derosa Thomas Joseph bought $3,299 worth of shares (10,000 units at $0.33), increasing direct ownership by 22% to 56,096 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    3/5/26 4:58:08 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    Director Lord Albert L bought $9,578 worth of shares (29,606 units at $0.32), increasing direct ownership by 0.91% to 3,300,000 units (SEC Form 4)

    4 - AppTech Payments Corp. (0001070050) (Issuer)

    3/5/26 4:57:43 PM ET
    $APCX
    Computer Software: Prepackaged Software
    Technology

    Director Ferber Alan bought $149,029 worth of shares (12,500 units at $11.92), increasing direct ownership by 19% to 77,134 units (SEC Form 4)

    4 - Sunrun Inc. (0001469367) (Issuer)

    3/4/26 4:06:55 PM ET
    $RUN
    Industrial Machinery/Components
    Miscellaneous

    $ACER
    $ACON
    $ANTE
    $APCX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for AMONDYS 45 issued to SAREPTA THERAPS INC

    Submission status for SAREPTA THERAPS INC's drug AMONDYS 45 (SUPPL-8) with active ingredient CASIMERSEN has changed to 'Approval' on 07/11/2024. Application Category: NDA, Application Number: 213026, Application Classification: Labeling

    7/12/24 4:40:36 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 20, 2024 - FDA Expands Approval of Gene Therapy for Patients with Duchenne Muscular Dystrophy

    For Immediate Release: June 20, 2024 Today, the U.S. Food and Drug Administration expanded the approval of Elevidys (delandistrogene moxeparvovec-rokl), a gene therapy for the treatment of Duchenne muscular dystrophy (DMD) for ambulatory and non-ambulatory individuals 4 years of age and older with DMD with a confirmed mutation in the DMD gene.  Elevidys was previously approved under accelerated approval for amb

    6/20/24 5:24:42 PM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for VYONDYS 53 issued to SAREPTA THERAPS INC

    Submission status for SAREPTA THERAPS INC's drug VYONDYS 53 (SUPPL-11) with active ingredient GOLODIRSEN has changed to 'Approval' on 06/04/2024. Application Category: NDA, Application Number: 211970, Application Classification: Labeling

    6/5/24 4:41:31 AM ET
    $SRPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACER
    $ACON
    $ANTE
    $APCX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT & CIO Sitomer Harrison was granted 85,492 shares, increasing direct ownership by 134% to 149,468 units (SEC Form 4)

    4 - SL GREEN REALTY CORP (0001040971) (Issuer)

    3/10/26 6:32:50 PM ET
    $SLG
    Real Estate Investment Trusts
    Real Estate

    New insider Sitomer Harrison claimed ownership of 63,976 shares (SEC Form 3)

    3 - SL GREEN REALTY CORP (0001040971) (Issuer)

    3/10/26 6:31:22 PM ET
    $SLG
    Real Estate Investment Trusts
    Real Estate

    Chief Commercial Officer Whitaker Corby C covered exercise/tax liability with 1,924 shares, decreasing direct ownership by 0.93% to 205,315 units (SEC Form 4)

    4 - ASPEN AEROGELS INC (0001145986) (Issuer)

    3/10/26 5:00:13 PM ET
    $ASPN
    RETAIL: Building Materials
    Consumer Discretionary

    $ACER
    $ACON
    $ANTE
    $APCX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Western Alliance Bancorp downgraded by TD Cowen with a new price target

    TD Cowen downgraded Western Alliance Bancorp from Buy to Hold and set a new price target of $83.00

    3/9/26 9:01:09 AM ET
    $WAL
    Major Banks
    Finance

    Western Alliance Bancorp upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Western Alliance Bancorp from Underweight to Equal Weight and set a new price target of $79.00

    3/9/26 8:45:28 AM ET
    $WAL
    Major Banks
    Finance

    Telsey Advisory Group reiterated coverage on Traeger with a new price target

    Telsey Advisory Group reiterated coverage of Traeger with a rating of Market Perform and set a new price target of $1.00 from $1.50 previously

    3/6/26 8:40:29 AM ET
    $COOK
    Consumer Electronics/Appliances
    Consumer Discretionary

    $ACER
    $ACON
    $ANTE
    $APCX
    Leadership Updates

    Live Leadership Updates

    View All

    Western Alliance Bank Names Kristen Hillenbrand Head of Treasury Management Sales

    Veteran treasury executive to lead national sales team, advance client-focused strategy Western Alliance Bank (NYSE:WAL) today announced that it has appointed Kristen Hillenbrand as Head of Treasury Management Sales, overseeing the bank's national treasury operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310685545/en/Kristen Hillenbrand, Head of Treasury Management Sales, Western Alliance Bank In this role, Hillenbrand leads a nationwide team of Treasury Management directors, officers, advisors, and payables and receivables consultants dedicated to designing and delivering tailored solutions and an elevated client

    3/10/26 6:47:00 PM ET
    $WAL
    Major Banks
    Finance

    Groupon Launches Board-Level Artificial Intelligence Committee and Appoints Amit Shah to Board of Directors

    Technology executive and AI entrepreneur to chair new committee as Company positions marketplace for the era of agentic commerceChicago, Illinois--(Newsfile Corp. - March 10, 2026) - Groupon, Inc. (NASDAQ:GRPN) today announced the appointment of Amit Shah to its Board of Directors, effective March 10, 2026, and the formation of a dedicated Artificial Intelligence Committee of the Board. Shah, a seasoned technology executive and AI entrepreneur, will serve as the Committee's inaugural Chair.With this action, Groupon becomes one of the first publicly traded consumer marketplaces to establish a board-level committee dedicated to artificial intelligence. The formation of the Committee reflects t

    3/10/26 4:15:00 PM ET
    $APRN
    $FLWS
    $GRPN
    Catalog/Specialty Distribution
    Consumer Discretionary
    Other Specialty Stores
    Advertising

    Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors

    GAITHERSBURG, Md., March 03, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of John D. Fowler, Jr. to its board of directors effective March 1, 2026. Mr. Fowler brings more than three decades of leadership experience across the healthcare and financial services sectors. He will serve on the Audit and Finance Committee. "We're pleased to welcome John to the board of directors at this important point in the company's ongoing turnaround and transformation," said Dr. Zsolt Harsanyi, Ph.D., chairman of the board. "John's deep experience in healthcare and financial markets will provide valuable insight as the company continues to execute against i

    3/3/26 8:00:00 AM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACER
    $ACON
    $ANTE
    $APCX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/13/24 10:39:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Oncocyte Corporation

    SC 13G/A - Oncocyte Corp (0001642380) (Subject)

    12/9/24 5:30:06 PM ET
    $OCX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/6/24 2:12:18 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    $ACER
    $ACON
    $ANTE
    $APCX
    Financials

    Live finance-specific insights

    View All

    Groupon Reports Fourth Quarter and Fiscal Year 2025 Results

    North America Q4 Local Revenue +4% and Local Billings +9%North America 2025 Local Revenue +5% and Local Billings +14%Positive Trailing twelve month operating cash flow from continuing operations of $64.5 million and Free Cash Flow of $49.9 millionChicago, Illinois--(Newsfile Corp. - March 10, 2026) - Groupon, Inc. (NASDAQ:GRPN) today announced its financial results for the quarter and year ended December 31, 2025 and provided details on its recent operating progress. The Company filed its Form 10-K with the Securities and Exchange Commission and posted earnings commentary including an updated presentation on its investor relations website (investor.groupon.com)."Our 2025 results represent a

    3/10/26 4:15:00 PM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Blend Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results

    Blend Labs, Inc. (NYSE:BLND), a leading origination platform for digital banking solutions, today announced its preliminary fourth quarter and full year 2025 financial results. Blend also announced that its Board of Directors authorized a share repurchase program providing for the repurchase of up to $50 million of its Class A common stock. "I am pleased to report that Blend finished fiscal year 2025 with a strong fourth quarter, coming in near the high end of our revenue guidance and beating the high end of our non-GAAP operating income guidance," said Nima Ghamsari, Co-founder and Head of Blend. "What excites me most going into 2026 is not just our growing roster of customers — it's wha

    3/10/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    Western Alliance Bancorporation Takes Decisive Action on LAM Trade Finance Loan

    Complaint Filed this Morning, Initiating Legal Action to Collect Amount Owed Charging-Off Remaining LAM I Loan Balance of $126.4 Million Financial Impact Substantially Mitigated Through Realization of Securities Sale Gains & Expense Reductions Western Alliance Bancorporation (the "Company") today announced that it has been informed by Jefferies Financial Group ("Jefferies") that payments of $126.4 million owed to Western Alliance Bank ("Bank") pursuant to a forbearance agreement will not be paid as agreed. Earlier this morning, the Bank and its Collateral Agent filed a Complaint in New York Supreme Court against Jefferies, Leucadia Asset Management LLC ("LAM"), and affiliates (c

    3/6/26 7:33:00 AM ET
    $WAL
    Major Banks
    Finance